SCIB1 is a melanoma DNA vaccine that incorporates specific epitopes from the proteins gp100 and TRP-2 within an antibody framework (ImmunoBody®), aiming to stimulate the patient’s T cells to emit a specific response to melanoma cells [103,104,105]. This evidence concerns the gene PMEL and melanoma.